JP Consulting’s clinical medicine team boasts a strong pharmaceutical background, led by experienced executives with extensive experience in both China and Australia. Our team is well-versed in the needs of Chinese pharmaceutical companies and thoroughly familiar with the drug development ecosystem and regulatory policies in China and Australia. As an Australian-based company dedicated to serving Chinese enterprises, we possess a wealth of clinical medicine support experience. We offer a comprehensive suite of services to Chinese companies venturing overseas, including clinical trial protocol design, investigator’s brochure (IB) review, independent medical monitoring, medical writing, medical monitoring and CSR review.​

When conducting clinical trials in Australia, most Chinese pharmaceutical companies, in addition to utilizing clinical CRO services, place a high priority on establishing a third-party Australian local independent medical monitoring mechanism. While clinical CROs provide a full range of clinical operations services, independent Australian local medical monitoring is crucial for eliminating potential biases in data collection and reporting, ensuring patient safety and data integrity throughout the trial, and guaranteeing high-quality clinical research. This two-pronged approach, combining the strengths of CROs with independent local medical monitoring, offers Chinese sponsors a safer and more comprehensive strategy for conducting clinical trials in Australia.